ERP Clinical Trials

1 recruiting

About ERP Clinical Trials

Looking for clinical trials for ERP? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new ERP trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about ERP clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 273 trials

Recruiting
Phase 2

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

Breast CarcinomaBreast Atypical Hyperplasia
National Cancer Institute (NCI)80 enrolled4 locationsNCT05941520
Recruiting
Phase 2

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Breast CarcinomaBreast Atypical Hyperplasia
National Cancer Institute (NCI)66 enrolled3 locationsNCT06195306
Recruiting

Natural History Study of Parathyroid Disorders

Primary HyperparathyroidismParathyroid CancerPseudohypoparathyroidism+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3,000 enrolled1 locationNCT04969926
Recruiting
Phase 2

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

Breast CarcinomaBreast Atypical Ductal HyperplasiaBreast Atypical Lobular Hyperplasia
National Cancer Institute (NCI)200 enrolled11 locationsNCT06184750
Recruiting

Natural History Study of Patients With Excess Androgen

Congenital Adrenal Hyperplasia (CAH)Familial Male-Limited Precocious Puberty (FMPP)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)3,000 enrolled2 locationsNCT00250159
Recruiting

Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer

Prostate CancerProstatic CancerProstatic Hyperplasia+1 more
National Cancer Institute (NCI)10,000 enrolled1 locationNCT03354416
Recruiting
Phase 3

Shingrix in Renal Transplant Recipients

Kidney FailureKidney TransplantationKidney Failure, Chronic+2 more
University of Colorado, Denver132 enrolled4 locationsNCT04128189
Recruiting
Not Applicable

Ambulatory Long Length URodynamics Evaluation

Benign Prostatic HyperplasiaUrodynamicsUrinary Bladder, Overactive+4 more
Bright Uro101 enrolled7 locationsNCT07425015
Recruiting
Phase 2Phase 3

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

Congenital Adrenal HyperplasiaClassic Congenital Adrenal Hyperplasia
Crinetics Pharmaceuticals Inc.153 enrolled24 locationsNCT07159841
Recruiting
Not Applicable

Painhunting Therapy for Interpersonal Loss-Related Depression

Loss-Related DepressionInterpersonal Loss
Painhunting LLP72 enrolled1 locationNCT07490691
Recruiting

Parathyroid Tumor Clonal Status

Primary HyperparathyroidismParathyroid Tumor
Washington University School of Medicine839 enrolled1 locationNCT05997810
Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Heart FailurePainInsomnia+22 more
Duke University5,000 enrolled51 locationsNCT04278404
Recruiting
Not Applicable

Efficacy of Electroacupuncture for Acute Herpes Zoster-Associated Pain and Biomarker Evaluation

Acute Herpes Zoster
Dexiong Han228 enrolled1 locationNCT07515885
Recruiting
Phase 3

Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months

Endometrial Hyperplasia
Bayer207 enrolled85 locationsNCT06904274
Recruiting
Phase 2

Y-4 to Treat the Postherpetic Neuralgia

Postherpetic NeuralgiaPregabalinY-4
Neurodawn Pharmaceutical Co., Ltd.160 enrolled1 locationNCT07275762
Recruiting
Phase 2

Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer

Prostatic HyperplasiaUrinary Urge IncontinenceStress Urinary Incontinence
National Cancer Institute (NCI)41 enrolled1 locationNCT06161506
Recruiting
Phase 2

Intrauterine Injection of Type III Collage in FST of EC/AEH

Endometrial CancerAtypical Endometrial Hyperplasia
Wang Jianliu30 enrolled1 locationNCT07377734
Recruiting

OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH

Benign Prostatic Hyperplasia
Urotronic Inc.500 enrolled9 locationsNCT06560476
Recruiting
Not Applicable

The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster

Postherpetic NeuralgiaPainHerpes Zoster
Beijing Tiantan Hospital832 enrolled1 locationNCT07361796
Recruiting
Phase 3

A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia

Congenital Adrenal HyperplasiaClassic Congenital Adrenal Hyperplasia
Crinetics Pharmaceuticals Inc.150 enrolled17 locationsNCT07144163